Prenatal and New-born Genetic Testing Market -2013-2019

Transparency Market Research Prenatal and New-born Genetic Testing Market is growing at a CAGR of 26.9% from 2013 to 2019. By Transparency Market Research.

Single User License:

USD 4595 Multi User License:

USD 7595 Corporate User License:

USD 10595

Published Date 21-March-2014

87 Page Report

Request Sample

Buy Now

Press Release

Prenatal and New-born Genetic Testing Market is growing at a CAGR of 26.9% from 2013 to 2019. By Transparency Market Research.

Transparency Market Research State Tower, 90, State Street, Suite 700.

Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com

Prenatal and Newborn Genetic Testing Market

REPORT DESCRIPTION

Prenatal and New-born Genetic Testing Market valued USD 1.12 billion in 2013 and expected to grow at a

CAGR of 26.9% from 2013 to 2019, to reach an estimated value of USD 8.37 billion in 2019.

Prenatal and newborn genetic testing is referred to the utilization of screening/diagnostic procedures for a fetus or a new born baby to detect chromosomal abnormalities such as Down syndrome, Patau syndrome and Edward syndrome. These testing procedures enable detection of certain genetic abnormalities in as early as 8 to 10 weeks of gestation and also help to determine the sex of the fetus. According to Northwestern Medical Faculty Foundation, Down syndrome, open neural tube defects and trisomy 18 are the birth defects that 85% of women are advised to be screened or tested during pregnancy. Whereas, there are some tests which provides information about trisomy 13 and other chromosome abnormalities. Prenatal and newborn genetic tests are of two types, diagnostic and screening tests. Diagnostic tests helps to confirm the presence of certain genetic conditions in a fetus or a new born baby, while screening tests detects the chance of development of certain genetic abnormalities in a fetus or new born baby.

Browse Global Prenatal and Newborn Genetic Testing Market Report with Full TOC at http://www.transparencymarketresearch.com/prenatal-new-born-genetic-testing.html The prenatal and newborn genetic testing market is driven by increasing maternal age and late pregnancies, technological advancements and growing awareness about genetic disorders in the fetus. It was also observed that the prenatal and newborn genetic testing market is still at a nascent stage and have many opportunities such as capitalizing on potential markets in the emerging Asian, African and Latin American countries.

In diagnostic techniques market, polymerase chain reaction (PCR) segment accounted for the largest share, as compared to FISH and aCGH. The PCR market is mainly driven by rising incidences of genetic diseases and forensics coupled with high process efficiency, better precision and reliability of the technique, and amplification. Non-invasive prenatal testing (NIPT) is the largest market segment in screening method and is expected to grow at highest CAGR of 37.6% from 2013 to 2019.

Transparency Market Research

2

Prenatal and Newborn Genetic Testing Market

The North American region accounted for the largest share of the total prenatal and newborn genetic testing market. One of the key factors driving the growth of North America market is the non-invasive nature of the test that completely eliminates the risk of miscarriage associated with invasive tests such as amniocentesis and CVS (Chorionic Villus Sampling).

The diagnostic testing techniques market consists of key players such as Bio-Rad Laboratories, Agilent Technologies, Perkin Elmer and Ariosa Diagnostics. Agilent Technologies and Bio-Rad Laboratories are the leading players in diagnostic testing techniques market because of their dominance in reagents and instruments market. Major players of the screening methods market are Sequenom, Inc., Illumina, Inc. and Natera, Inc. Overall Sequenom, Inc. and Verinata Health are the major market players of the global prenatal and newborn genetic testing market because of their initial product launches in this market.

The global prenatal and newborn genetic testing market is segmented as follows: Prenatal and Newborn Genetic Testing Market, by Technology Diagnostic Techniques Polymerase Chain Reaction (PCR) Fluorescence In-Situ Hybridization (FISH) Array-Comparative Genomic Hybridization (aCGH) Screening Methods Non-invasive Prenatal Tests (MaterniT21 PLUS, Verifi, Harmony, Panorama, NIFTY, PrenaTest and Bambni Test) Maternal Serum Screening (MSS) Prenatal and Newborn Genetic TestingMarket, by Geography North America Europe

Transparency Market Research

3

Prenatal and Newborn Genetic Testing Market Asia-Pacific Rest of the World (RoW) For Sample Report Visit On: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1744

TABLE OF CONTENT

Table of Content Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Sources 1.4 List of Abbreviations

Chapter 2 Executive Summary 2.1 Market Snapshot: Global Prenatal and Newborn Genetic Testing Market (2012 & 2019) 2.2 Global Prenatal and Newborn Genetic Testing Market, by Segments, 2012 (USD Million)

Chapter 3 Prenatal and Newborn Genetic Testing Market Overview

Transparency Market Research

4

Prenatal and Newborn Genetic Testing Market 3.1 Introduction and Market Definition 3.2 Future Market Outlook 3.3 Regulatory and Reimbursement Scenario for Prenatal and Newborn Screening 3.4 Market Dynamics 3.4.1 Drivers 3.4.2 Restraints 3.4.3 Market Opportunities 3.5 Porter’s Five Forces Analysis: Global Prenatal and Newborn Genetic Testing Market 3.5.1 Bargaining Power of Suppliers 3.5.2 Bargaining Power of Buyers 3.5.3 Threat of Substitutes 3.5.4 Threat of New Entrants 3.5.5 Competitive Rivalry 3.6 Market Attractiveness Analysis

Chapter 4 Prenatal and Newborn Genetic Testing Market, by Technology 4.1 Overview 4.1.1 Global Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 – 2019 (USD Million) 4.2 Diagnostic Techniques

Transparency Market Research

5

Prenatal and Newborn Genetic Testing Market 4.2.1 Global Diagnostic Techniques Market Revenue, by Types, 2012 – 2019 (USD Million) 4.2.2 Polymerase Chain Reaction (PCR) 4.2.3 Fluorescence In-Situ Hybridization (FISH) 4.2.4 Array-Comparative Genomic Hybridization (aCGH) 4.3 Screening Methods 4.3.1 Global Screening Methods Market Revenue, by Types, 2012 – 2019 (USD Million) 4.3.2 Non-invasive Prenatal Tests (MaterniT21 PLUS, Verifi, Harmony, Panorama, NIFTY, PrenaTest and Bambni Test) 4.3.3 Maternal Serum Screening (MSS)

Chapter 5 Prenatal and Newborn Genetic Testing Market, by Geography 5.1 Overview 5.1.1 Global Prenatal and Newborn Genetic Testing Market Revenue, by Geography2012 – 2019 (USD Million) 5.2 North America 5.2.1 North America Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million) 5.2.2 North America Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million) 5.2.3 North America Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)

Transparency Market Research

6

Prenatal and Newborn Genetic Testing Market 5.3 Europe 5.3.1 Europe Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 2019 (USD Million) 5.3.2 Europe Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million) 5.3.3 Europe Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million) 5.4 Asia - Pacific 5.4.1 Asia-Pacific Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million) 5.4.2 Asia-Pacific Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million) 5.4.3 Asia-Pacific Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million) 5.5 Rest of the World (RoW) 5.5.1 RoW Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 2019 (USD Million) 5.5.2 RoW Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million) 5.5.3 RoW Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)

Chapter 6 Competitive Landscape 6.1 Market Share Analysis, by Key Players, 2012 (%)

Chapter 7 Recommendations

Transparency Market Research

7

Prenatal and Newborn Genetic Testing Market 7.1 Market Strategy for Success 7.1.1 Focus on forming alliances with diagnostic service providers in Asia-Pacific countries 7.1.2 Emphasis on improving technology in order to increase accuracy, reduce the duration of result generation and price 7.2 Barriers and Future Assumptions 7.2.1 Lack of awareness about prenatal and newborn genetic testing in some Asian countries 7.2.2 Regulatory compliance and ethical issues

Chapter 8 Company Profiles 8.1 Agilent Technologies, Inc. 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Ariosa Diagnostics, Inc. 8.2.1 Company Overview 8.2.2 Financial Overview 8.2.3 Product Portfolio

Transparency Market Research

8

Prenatal and Newborn Genetic Testing Market 8.2.4 Business Strategies 8.2.5 Recent Developments 8.3 Bio-Rad Laboratories, Inc. 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 Illumina, Inc. 8.4.1 Company Overview 8.4.2 Financial Performance 8.4.3 Product Portfolio 8.4.4 Business Strategies 8.4.5 Recent Developments 8.5 Laboratory Corporation of America Holdings (LabCorp) 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio 8.5.4 Business Strategies

Transparency Market Research

9

Prenatal and Newborn Genetic Testing Market 8.5.5 Recent Developments 8.6 Natera, Inc. 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments 8.7 PerkinElmer, Inc. 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategies 8.7.5 Recent Developments 8.8 Sequenom, Inc. 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Business Strategies 8.8.5 Recent Developments

Transparency Market Research

10

Prenatal and Newborn Genetic Testing Market

About Us

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/

Transparency Market Research

11